Form 8-K - Current report:
SEC Accession No. 0001213900-25-095847
Filing Date
2025-10-03
Accepted
2025-10-03 08:16:13
Documents
16
Period of Report
2025-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0259860-8k_onconetix.htm   iXBRL 8-K 85756
2 CERTIFICATE OF DESIGNATIONS AUTHORIZING THE ISSUANCE OF THE SERIES E PREFERRED S ea025986001ex3-1_onconetix.htm EX-3.1 318227
3 FORM OF WARRANT ea025986001ex4-1_onconetix.htm EX-4.1 185174
4 FORM OF SECURITIES PURCHASE AGREEMENT DATED OCTOBER 1, 2025 RELATING TO THE SALE ea025986001ex10-1_onconetix.htm EX-10.1 298099
5 FORM OF REGISTRATION RIGHTS AGREEMENT DATED AS OF OCTOBER 1, 2025 RELATING TO TH ea025986001ex10-2_onconetix.htm EX-10.2 177046
  Complete submission text file 0001213900-25-095847.txt   1497986

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE onco-20251001.xsd EX-101.SCH 3017
7 XBRL LABEL FILE onco-20251001_lab.xml EX-101.LAB 34239
8 XBRL PRESENTATION FILE onco-20251001_pre.xml EX-101.PRE 22360
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0259860-8k_onconetix_htm.xml XML 3795
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 251372128
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)